Literature DB >> 22808564

Epidemiology of neonatal jaundice at the University Hospital of the West Indies.

C Henny-Harry1, H Trotman.   

Abstract

OBJECTIVE: To describe the epidemiology of neonatal jaundice at the University Hospital of the West Indies (UHWI).
METHODS: A retrospective review of all neonates at the UHWI with clinically significant jaundice between January 1, 2006 and June 30, 2007 was performed. Demographic, clinical and laboratory data were collected. Descriptive analyses were performed.
RESULTS: The incidence of clinically significant neonatal jaundice at the UHWI was 4.6% for the study period. There were 103 male (61%) and 67 (39%) female infants. The aetiology ofjaundice in the infant was attributed to ABO incompatibility in 59 (35%), infection in 30 (18%), prematurity in 19 (11%), G6PD deficiency in 8 (5%), Rhesus incompatibility in 6 (3.5%) and no cause was identified in 16 (9%) infants. There was a low incidence (26%) ofscreening for G6PD deficiency although it was the most common aetiology for infants presenting from home. Nine (5%) neonates required exchange blood transfusion. Infants admitted from home had a significantly higher mean total bilirubin value at presentation, a significantly higher mean peak bilirubin level andpresented significantly later than those who were admitted from the postnatal ward (p < 0.001). One patient was discharged with a diagnosis of bilirubin encephalopathy but defaulted from follow-up. Two neonates died but from causes unrelated to neonatal jaundice. Sixty-two patients (37%) were followed-up post discharge; 50% had hearing tests done, all tests were normal. Sixty-one (98%) infants had normal development at the time of the study; one patient had impaired motor development but this infant also had a myelomeningocoele.
CONCLUSION: To further reduce morbidity associated with neonatal jaundice at the UHWI, there should be increased screening for G6PD deficiency; current systems in place for follow-up and monitoring of infants discharged from hospital prior to 72 hours must also be expanded and strengthened.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22808564

Source DB:  PubMed          Journal:  West Indian Med J        ISSN: 0043-3144            Impact factor:   0.171


  7 in total

Review 1.  Glucose-6-Phosphate Dehydrogenase Deficiency and the Need for a Novel Treatment to Prevent Kernicterus.

Authors:  Anna D Cunningham; Sunhee Hwang; Daria Mochly-Rosen
Journal:  Clin Perinatol       Date:  2016-02-28       Impact factor: 3.430

2.  [Effectiveness of Saccharomyces boulardii combined with phototherapy in the treatment of hyperbilirubinemia in neonates: a prospective randomized controlled trial].

Authors:  Wei Tang; Hong-Yan Lu; Qin Sun; Wei-Min Xu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-11

Review 3.  Etiology and therapeutic management of neonatal jaundice in Iran: a systematic review and meta-analysis.

Authors:  Yadollah Zahed Pasha; Shaghayegh Alizadeh-Tabari; Ermia Zahed Pasha; Mohammad Zamani
Journal:  World J Pediatr       Date:  2020-02-12       Impact factor: 2.764

4.  Ischaemic Priapism and Glucose-6-Phosphate Dehydrogenase Deficiency: A Mechanism of Increased Oxidative Stress?

Authors:  B F Morrison; E B Thompson; S D Shah; G H Wharfe
Journal:  West Indian Med J       Date:  2014-08-21       Impact factor: 0.171

5.  G6PD Enzyme Deficiency in Neonatal Pathologic Hyperbilirubinemia in Yazd.

Authors:  M Pahlavanzadeh; S Hekmatimoghaddam; M Teremahi Ardestani; M Ghafoorzadeh; Mm Aminorraaya
Journal:  Iran J Ped Hematol Oncol       Date:  2013-04-22

Review 6.  Clinical complications of G6PD deficiency in Latin American and Caribbean populations: systematic review and implications for malaria elimination programmes.

Authors:  Wuelton M Monteiro; Gabriel P Franca; Gisely C Melo; Amanda L M Queiroz; Marcelo Brito; Henry M Peixoto; Maria Regina F Oliveira; Gustavo A S Romero; Quique Bassat; Marcus V G Lacerda
Journal:  Malar J       Date:  2014-02-25       Impact factor: 2.979

7.  Hyperbilirubinemia in Preterm Infants Admitted to Neonatal Intensive Care Units in Ethiopia.

Authors:  Sara Aynalem; Mahlet Abayneh; Gesit Metaferia; Abayneh G Demissie; Netsanet Workneh Gidi; Asrat G Demtse; Hailu Berta; Bogale Worku; Assaye K Nigussie; Amha Mekasha; Zelalem Tazu Bonger; Elizabeth M McClure; Robert L Goldenberg; Lulu M Muhe
Journal:  Glob Pediatr Health       Date:  2020-12-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.